ConferencePoster
 (2017)

CTGF/CCN2 activity inhibition reduces fibrosis and improves muscle and locomotor function in an ALS model

Gonzalez, D.; Rebolledo D.; Court, F; Lipson K; Cerpa W.; van Zundert B.; Brandan E.